Cardinal Keeler Criticizes Senate Majority Leader Frist's Statement on Embryonic Stem-Cell Research
Posted on: Friday, 29 July 2005, 18:00 CDT
WASHINGTON, July 29 /U.S. Newswire/ -- Cardinal William H. Keeler, chairman of the U.S. Bishops' Committee for Pro-life Activities, criticized Senate Majority Leader Bill Frist's announcement today that he will support federally funded stem cell research that requires destroying human embryos.
Cardinal Keeler's statement follows.
"Today Senate Majority Leader Bill Frist announced he will support using federal funds to encourage the destruction of living human embryos for their stem cells. Despite the Senator's disclaimers to the contrary, this position is not 'pro-life.'
"Especially disturbing is the Senator's insistence that human embryos unwanted by their own parents are owed 'the same dignity and respect' as children and adults, but may nevertheless be killed for research material. Such destruction of innocent human life, even out of a desire to help others, rests on a utilitarian view that undermines human dignity and human respect, as Senator Sam Brownback ably pointed out today in his response. Senator Frist's effort to make an analogy with organ transplants also fails, because it would be gravely immoral as well as illegal to harvest any patient's vital organs when he or she is still alive.
"Despite his warning against offering 'false hope' to patients, Senator Frist also repeated claims that are untrue or misleading about the unique 'promise' of embryonic stem cells. No one has identified any disease that can be treated only with these cells; no one even knows whether they will ever provide a safe and reliable treatment for the conditions already being successfully treated using adult stem cells. These factual issues will no doubt be explored by others. My own central concern is that neither sound ethics nor good government can rest on the principle that 'the end justifies the means.' I commend President Bush for his laudable pledge to veto such legislation."
http://www.usnewswire.com
Source: U.S. Newswire
Related Articles
- Invitrogen and WARF Sign License Agreement for Human Embryonic Stem Cells
- International Stem Cell Corporation's Human Parthenogenetic Stem Cells to Be Used in Germany in the Development of Treatments for Neural Disease
- Millipore and Stem Cell Sciences Announce Agreement To Provide Human Embryonic Stem Cell Media
- Derivation of Human Embryonic Stem Cells From Developing and Arrested Embryos
- Advanced Cell Technology Announces Technique to Generate Human Embryonic Stem Cells That Maintains Developmental Potential of Embryo; Approach Published in Nature
- Geron Announces Improved Production Method for Human Embryonic Stem Cell-Derived Islet Cells
- Chemicon International Announces Agreement With Axordia for Exclusive Co-Development of Human Embryonic Stem Cell Antibody Markers
- Chemicon International, Inc. Enters into a License to Commercialize Research Products Utilizing Human Embryonic Stem Cell Technology From Wisconsin Alumni Research Foundation (WARF)
- Senate Stem Cell Study Advocates Skeptical
- Embryonic Death and the Creation of Human Embryonic Stem Cells
 |
 |
User Comments (0)
RSS Feeds